Heart Valve Involvement in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Study of a Single Centre
Background: Valve involvement is the most common cardiac manifestation in antiphospholipid syndrome (APS). The objective of the study was to describe the prevalence, clinical and laboratory features, and evolution of APS patients with heart valve involvement. Methods: A retrospective longitudinal an...
Main Authors: | Isaac Pons, Joana Louro, Marta Sitges, Bàrbara Vidal, Ricard Cervera, Gerard Espinosa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/8/2996 |
Similar Items
-
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
by: M. Taraborelli, et al.
Published: (2016-12-01) -
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by: Lucas Jacobs, et al.
Published: (2024-03-01) -
Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?
by: Riccardo Tomasello, et al.
Published: (2021-09-01) -
Clinical case of rheumatoid arthritis with antiphospholipid antibody syndrome
by: G. G Arabidze, et al.
Published: (2015-09-01) -
Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series
by: Shawn A. Mahmud, et al.
Published: (2022-08-01)